oxamniquine has been researched along with DDD MPGNII in 1 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nephrotic syndrome was the most frequent clinical presentation in both groups." | 1.28 | Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy. ( Brito, E; Martinelli, R; Noblat, AC; Rocha, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martinelli, R | 1 |
| Noblat, AC | 1 |
| Brito, E | 1 |
| Rocha, H | 1 |
1 other study available for oxamniquine and DDD MPGNII
| Article | Year |
|---|---|
Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
Topics: Adult; Antihypertensive Agents; Cyclophosphamide; Diet, Sodium-Restricted; Diuretics; Female; Follow | 1989 |